| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.33 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |